Market Overview:
The global Tramadol HCL market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of chronic pain, increasing demand for pain relief drugs, and growing awareness about Tramadol HCL. Based on type, the global Tramadol HCL market is segmented into intramuscular injection, oral, and rectal administration. The intramuscular injection segment is expected to account for the largest share of the global Tramadol HCL market in 2018. This can be attributed to its ease of use and fast onset of action. Based on application, the global Tramadol HCl market is segmented into hospital, clinic, and medical center.
Product Definition:
Tramadol hydrochloride is a synthetic opioid analgesic used to treat moderate to severe pain. It is available in both oral and intravenous formulations.
Intramuscular Injection:
Intramuscular injection is a procedure wherein the drug is injected into muscle. Intra-muscular injections are used in cases where oral medications are ineffective or when patients do not have sufficient strength to administer the medication themselves. The most common types of intramuscular injections include anabolic steroids, insulin, and local anesthetics including bupivacaine.
Oral:
Oral is a form of drug administration by which the drug is administered in tablet or capsule form. The oral route of administration offers several advantages such as ease of use, self-containment, and minimal risk to the patient. Moreover, it also helps in reducing the cost incurred for storage and preservation of drugs.
Application Insights:
The global tramadol hydrochloride market is segmented based on application into hospital, clinic, and medical center. The hospital segment dominated the overall market in terms of revenue in 2017 owing to high usage rates of this drug for pain management and treatment of various other diseases. In addition, increasing incidences of chronic pains due to an increase in the working-age population coupled with rising awareness about pain management are expected to drive demand over the forecast period.
Tramadol has a wide range of applications across different disease categories such as neurogenic, arthritic & musculoskeletal conditions (rheumatoid arthritis), cancer (breast cancer), cardiovascular disorders (coronary artery disease), respiratory problems (asthma) and gastrointestinal conditions (gastrointestinal disorder). Increasing prevalence along with growing awareness about these applications is anticipated to fuel growth during the forecast period.
Regional Analysis:
Europe dominated the global tramadol HCL market in terms of revenue with a share of over 40.0% in 2017. This is attributed to the presence of major tramadol manufacturing facilities and high patient awareness levels coupled with relatively higher healthcare expenditure levels as compared to other regions. The Asia Pacific region is expected to witness lucrative growth opportunities during the forecast period owing to increasing demand for pain management treatment options, rising number of patients suffering from chronic pain conditions, and growing medical tourism industry in this region.
The key manufacturers operating in this space include Mylan N.V., Pfizer Inc., Actavis Pharma A/S, Cipla Inc., Sun Pharmaceutical Industries Ltd., Dr Reddy’s Laboratories Ltd.
Growth Factors:
- Increasing awareness about the benefits of Tramadol HCL among consumers and healthcare professionals.
- Rising incidence of chronic pain across the globe, which is expected to increase demand for Tramadol HCL in the coming years.
- Growing number of product approvals and launches by key players in the market space.
- increasing research and development investments by manufacturers to develop new formulations and delivery methods for Tramadol HCL products
Scope Of The Report
Report Attributes
Report Details
Report Title
Tramadol HCL Market Research Report
By Type
Intramuscular Injection, Oral, Rectal Administration
By Application
Hospital, Clinic, Medical Center
By Companies
Grnenthal GmbH, Mundipharma, Hexal AG, Labopharm, Pliva Pharma, Nippon Shinyaku, Atoz Pharmaceuticals, Rompharm Company, Amneal Pharmaceuticals, Par Pharmaceutical, Kosher Pharmaceuticals, CSPC, Xinhua Pharmaceutical, Tianlong Shiye, Southwest Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Tramadol HCL Market Report Segments:
The global Tramadol HCL market is segmented on the basis of:
Types
Intramuscular Injection, Oral, Rectal Administration
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Medical Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Grnenthal GmbH
- Mundipharma
- Hexal AG
- Labopharm
- Pliva Pharma
- Nippon Shinyaku
- Atoz Pharmaceuticals
- Rompharm Company
- Amneal Pharmaceuticals
- Par Pharmaceutical
- Kosher Pharmaceuticals
- CSPC
- Xinhua Pharmaceutical
- Tianlong Shiye
- Southwest Pharmaceutical
Highlights of The Tramadol HCL Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intramuscular Injection
- Oral
- Rectal Administration
- By Application:
- Hospital
- Clinic
- Medical Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tramadol HCL Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tramadol HCL is a synthetic opioid analgesic that is used to relieve pain. It is also known by the trade name Ultram.
Some of the major companies in the tramadol hcl market are Grnenthal GmbH, Mundipharma, Hexal AG, Labopharm, Pliva Pharma, Nippon Shinyaku, Atoz Pharmaceuticals, Rompharm Company, Amneal Pharmaceuticals, Par Pharmaceutical, Kosher Pharmaceuticals, CSPC, Xinhua Pharmaceutical, Tianlong Shiye, Southwest Pharmaceutical.
The tramadol hcl market is expected to register a CAGR of 3.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tramadol HCL Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tramadol HCL Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tramadol HCL Market - Supply Chain
4.5. Global Tramadol HCL Market Forecast
4.5.1. Tramadol HCL Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tramadol HCL Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tramadol HCL Market Absolute $ Opportunity
5. Global Tramadol HCL Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tramadol HCL Market Size and Volume Forecast by Type
5.3.1. Intramuscular Injection
5.3.2. Oral
5.3.3. Rectal Administration
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tramadol HCL Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tramadol HCL Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Medical Center
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tramadol HCL Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tramadol HCL Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tramadol HCL Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tramadol HCL Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tramadol HCL Demand Share Forecast, 2019-2026
9. North America Tramadol HCL Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tramadol HCL Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tramadol HCL Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Medical Center
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tramadol HCL Market Size and Volume Forecast by Type
9.7.1. Intramuscular Injection
9.7.2. Oral
9.7.3. Rectal Administration
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tramadol HCL Demand Share Forecast, 2019-2026
10. Latin America Tramadol HCL Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tramadol HCL Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tramadol HCL Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Medical Center
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tramadol HCL Market Size and Volume Forecast by Type
10.7.1. Intramuscular Injection
10.7.2. Oral
10.7.3. Rectal Administration
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tramadol HCL Demand Share Forecast, 2019-2026
11. Europe Tramadol HCL Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tramadol HCL Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tramadol HCL Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Medical Center
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tramadol HCL Market Size and Volume Forecast by Type
11.7.1. Intramuscular Injection
11.7.2. Oral
11.7.3. Rectal Administration
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tramadol HCL Demand Share, 2019-2026
12. Asia Pacific Tramadol HCL Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tramadol HCL Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tramadol HCL Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Medical Center
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tramadol HCL Market Size and Volume Forecast by Type
12.7.1. Intramuscular Injection
12.7.2. Oral
12.7.3. Rectal Administration
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tramadol HCL Demand Share, 2019-2026
13. Middle East & Africa Tramadol HCL Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tramadol HCL Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tramadol HCL Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Medical Center
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tramadol HCL Market Size and Volume Forecast by Type
13.7.1. Intramuscular Injection
13.7.2. Oral
13.7.3. Rectal Administration
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tramadol HCL Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Tramadol HCL Market: Market Share Analysis
14.2. Tramadol HCL Distributors and Customers
14.3. Tramadol HCL Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Grnenthal GmbH
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mundipharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hexal AG
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Labopharm
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pliva Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nippon Shinyaku
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Atoz Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Rompharm Company
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Amneal Pharmaceuticals
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Par Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Kosher Pharmaceuticals
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. CSPC
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Xinhua Pharmaceutical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Tianlong Shiye
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Southwest Pharmaceutical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
